Kidney Dialysis

If you or a family member suffered a cardiovascular event within 72 hours of receiving a dialysis treatment from FRESENIUS MEDICAL CARE between 2004 and 2012, contact:

Some patients receiving GranuFlo and NaturaLyte, dialysis additives manufactured by Fresenius Medical Care, have experienced a heart attack, stroke, congestive heart failure or death after receiving a treatment. Our staff and attorneys will work aggressively to investigate and pursue your claim, as you may be entitled to compensation.

Fresenius first introduced these dialysis products in 2003. By 2012, said products were used for a majority of hemodialysis patients in the United States. NaturaLyte and Granuflo convert to bicarbonate, and these higher pre-dialysis levels pose a substantial risk of problems, including serious cardiac arrest and death. In the face of these extreme dangers, Fresenius took no action to warn doctors or patients.

Connect with us

Contact The Firm

PhonePlease enter a valid phone number. You may use 0-9, spaces and the ( ) - + characters.

Brief description of your legal issue

Please verify that you have read the disclaimer.I have read the
disclaimer.disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.